Agendia appointed last week six new members to its clinical and scientific advisory board. The advisors will review early research programs and provide academic and clinical evaluations. The advisory board will be chaired by Piet Borst, emeritus director of the Netherlands Cancer Institute.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.